Lung cancer screening programs that utilize standardized reporting and include cardiothoracic surgeons as part of a multidisciplinary team can successfully be adopted into clinical practice without an ...

Most high-risk lung cancer patients might not need annual low-dose computed tomography (LDCT) screenings if they are cleared of disease in their initial test, according to a study led by a Duke Cancer ...

With most lung cancers in India diagnosed at advanced stages, experts say low-dose CT screening for high-risk groups like ...

Low-dose computed tomography (LDCT), a procedure that uses X-rays to produce a series of images at different angles, generating a 3-dimensional view of the lung, is an effective screening technique ...

A secondary analysis of the National Lung Screening Trial (NLST) has found that low-dose (LDCT) lung cancer screening is actually more effective for older high-risk patients than it is for younger ...

Lung cancer remains one of the deadliest cancers, responsible for 1 in 4 cancer deaths in the US. Historically, it has been one of the most difficult to manage and cure. However, “the research story ...

The California Technology Assessment Forum is requested to review the scientific evidence for the use of low dose spiral computerized tomography (LDCT) as a modality for lung cancer screening. CTAF ...

Lung cancer cases are rising among younger, nonsmoking populations, particularly in Asia. One-time screening in a study from China led to biopsy-proven lung cancer diagnosis in 1.7% of an all-comer ...

OAK BROOK, Ill. – Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic ...

The STAMPEDE2 trial: A site survey of current patterns of care, access to imaging, and treatment of metastatic prostrate cancer in Nigeria. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

The MarketWatch News Department was not involved in the creation of this content. WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of ...